USPTO serial 99191977
SILOAM VISION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 4, 2026
- Examiner
- NOVAKOVIC, MIROSLAV
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SILOAM VISION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Portland, OR, US
Portland, OR, US
Portland, OR, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher A. DiSchino
Christopher A. DiSchino DiSchino & Schamy, PLLC4770 BISCAYNE BLVDSuite 600Miami, FL 33137Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical equipment, namely, computed tomography (CT) apparatus; Medical apparatus and instruments for use in positron emission tomography (PET) imaging; Medical device, namely, a device for measuring arterial blood flow in the eye; Medical imaging devices for eyes; Eye testing apparatus; Eye testing machines and apparatus; Medical device that scans the eyes for assessment of traumatic brain injury; Medical apparatus, namely, an injectable oxygen delivery system comprising an oxygen device which produces nanobubbles and nanobatteries to prevent or treat eye disease | ACTIVE | May 16, 2022 |
| 042 | Software as a service (SAAS) services featuring software for remote access to, storage of, and review of diagnostic images, integrating imaging data into patient records and enabling real-time access to ophthalmic diagnostic information; Software as a service (SAAS) services featuring software for managing the scheduling, coordination, and documentation of Retinopathy of Prematurity screening exams, including guided scheduling based on patient risk factors and compliance with clinical protocols; Software as a service (SAAS) services featuring software for enabling collaborative care management, streamlining healthcare workflows, and improving operational efficiency in neonatal ophthalmology practices; Software as a service (SAAS) services featuring software for cloud-based platforms for storage, management, analysis, and retrieval of ophthalmic diagnostic images and data obtained from optical coherence tomography (OCT) and scanning laser ophthalmoscopy (SLO) systems; Software as a service (SAAS) services featuring software for artificial intelligence-powered applications for automated detection, analysis, and severity scoring of pediatric retinal diseases and retinopathy of prematurity (ROP) in ophthalmic images; Software as a service (SAAS) services featuring software for clinical workflow platforms for ophthalmology practices providing patient scheduling, documentation, image review, remote clinician access, and integrated diagnostic tool; Software as a service (SAAS) services featuring software for cloud-based artificial intelligence solutions for ophthalmic image interpretation, disease screening, diagnostic support, and clinical decision-making in pediatric ophthalmology; Software as a service (SAAS) services featuring software for automated appointment reminders, patient care notifications, customizable alerts regarding patient milestones, and communication between referring physicians and specialists; Software as a service (SAAS) services featuring software for comprehensive image management systems for ophthalmologists and eye care professionals to securely store, access, share, and analyze diagnostic eye imaging from multiple modalities and devices; Software as a service (SAAS) services featuring software for integrated clinical dashboards, customizable worklists, and secure user portals designed to facilitate ophthalmic telemedicine consultations, remote patient monitoring, interdisciplinary care coordination, and collaborative clinical decision-making across healthcare networks | ACTIVE | May 16, 2022 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SILOAM VISION, INC.
- Other trademarks owned by SILOAM VISION, INC.
- Other trademarks owned by SILOAM VISION, INC.
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named SILOAM VISION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 4, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 16, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 16, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 10, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 22, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 30, 2025 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 27, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 22, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 22, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 22, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 14, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 26, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 19, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 19, 2025 | NWAP | NEW APPLICATION ENTERED | — |